Cargando…
Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma
Glioblastoma (GBM) is the most common and aggressive malignant glioma, treatment of which has not improved significantly in many years. This is due to the unique challenges that GBM tumors present when designing and implementing therapies. Recently, immunotherapy in the form of immune checkpoint inh...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215941/ https://www.ncbi.nlm.nih.gov/pubmed/32316096 http://dx.doi.org/10.3390/ijms21082759 |